Kala Pharmaceuticals (KALA) Reports Q2 Loss of $4.36

Go back to Kala Pharmaceuticals (KALA) Reports Q2 Loss of $4.36
(NASDAQ: KALA) Delayed: 3.23 -0.31 (8.76%)
Previous Close $3.54    52 Week High
Open $3.36    52 Week Low
Day High $3.54    P/E N/A 
Day Low $3.23    EPS
Volume 35,899